Skip to content
Biotechnology

Transforming Children’s Lives: DP World’s Aviv Clinics Dubai’s Revolutionary Youth Protocol

Aviv Clinics 3 mins read

DP World's Aviv Clinics Dubai’s Revolutionary Youth Protocol

DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) -- At DP World's Aviv Clinics Dubai, the world’s most advanced brain and body performance clinic, we understand the heartache parents feel when their child's development is hindered by conditions like cerebral palsy, autism spectrum disorder, traumatic brain injury, and other neurological conditions. Watching a child struggle without clear answers is a devastating experience for any parent. Our mission is to provide clarity and hope through our state-of-the-art youth protocol, a program dedicated to diagnosing and treating these conditions to help children reach their full potential.

The journey begins with our comprehensive youth assessment. This critical first step involves evaluating your child's cognitive and physical health with extensive testing conducted by our world-class physicians and medical professionals. The assessment includes a detailed medical history, cognitive and physical exams, blood tests and specialized assessments, like speech and occupational therapy, based on each child’s needs. We also perform advanced genetic testing and brain imaging using MRI technology to uncover the root causes of developmental delays.

Understanding and diagnosing your child's specific condition is fundamental to providing effective care. Our assessment addresses critical questions about causes and potential treatment outcomes for your child's development.

Once the assessment is complete, if your child is found suitable for the program, our clinical team formulates a personalized treatment plan based on the assessment testing results. Each child’s plan combines a unique hyperbaric oxygen therapy (HBOT) protocol, cognitive training, nutritional guidance, and physical, occupational and speech therapies. HBOT involves breathing pure oxygen in a pressurized chamber, boosting oxygen levels in the blood and tissue, which promotes healing, stimulates brain function and neuroplasticity. Cognitive training helps improve attention, social skills, and information processing, while our tailored nutritional plans ensure your child receives the essential nutrients needed for optimal health and healing. Physical, occupational and speech therapies enhance physical, sensory and communication skills and improve the overall clinical outcomes.

At DP World's Aviv Clinics Dubai, our holistic approach goes beyond treating symptoms; we focus on the cause of the symptoms to treat the whole child, aiming to improve their development, independence and overall quality of life. Our commitment is to support each child in achieving their full potential, aiming to provide families with the answers to the difficult questions, and manage expectations for treatment outcomes.

If your child is facing developmental issues and you’re looking for a clear diagnosis or answers to your questions, contact us today to learn about our youth assessment and treatment programs. As a child heals, the family heals. Together, we can help your child live their best life.

For media inquiries please contact
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5bd1bb6e-8e07-4cd1-b1a1-320332a505c2


Primary Logo

More from this category

  • Biotechnology
  • 12/12/2025
  • 11:40
4DMedical Limited (ASX:4DX)

4DMedical secures $30.2 million with options underwrite

Highlights• $30.2 million in funding secured by entering into an underwriting agreement that ensures the exercise of all the 4DXO listed options• Additional funding results in a proforma cash balance as at 30 September 2025 of $63.7 million • 4DMedical is experiencing unprecedented interest in CT:VQ™, with multiple contract discussions underway, positioning CY26 as a transformational year Melbourne, Australia, 12 December 2025: 4DMedical Limited (ASX: 4DX, “4DMedical” or the “Company”) today announces it has entered into an option underwriting agreement (Underwriting Agreement) with Bell Potter Securities Limited (Underwriter) to fully underwrite the exercise of the 4DXO listed options on issue,…

  • Biotechnology
  • 12/12/2025
  • 10:58
EBR Systems, Inc. (ASX:EBR)

First implant in the Totally Leadless CRT (TLC-AU) Study

Key Highlights • First patient enrolment and implant in the Totally Leadless CRT (TLC-AU) study by Dr Paul Gould from the Princess Alexandra Hospital, Brisbane • TLC-AU is a feasibility study into using the WiSE® System alongside a leadless pacemaker to achieve totally leadless CRT • The study represents a significant strategic milestone as EBR evaluates WiSE as a potential first-line therapy for treating newly diagnosed heart failure patients • TLC-AU could meaningfully expand EBR’s addressable market Sunnyvale, California; 12 December 2025: EBR Systems, Inc., developer of the world’s only wireless cardiac pacing device for heart failure, announces the first…

  • Biotechnology
  • 10/12/2025
  • 10:19
OncoSil Medical Limited (ASX:OSL)

First OncoSil treatment in United Kingdom

Sydney, Australia – 10 December 2025: OncoSil Medical Limited (ASX: OSL) (“OncoSil Medical” or “the Company”), a medical device company focused on localised treatments for patients with unresectable locally advanced pancreatic cancer (LAPC), is pleased to announce the first commercial patient treatment in the UK using the OncoSil™ device. The successful treatment was performed on 9 December 2025 at Southampton General Hospital (University Hospital SouthamptonNHS Foundation Trust), a recognised centre of excellence in oncology. Following the hospital’s participation in the TRIPP-FFX clinical study, this significant milestone marks the transition from clinical trial involvement to the commencement of OncoSil’s commercial operations…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.